Vaccines to Prevent Pneumococcal Community-Acquired Pneumonia

Cornelis H. van Werkhoven; Susanne M. Huijts

doi:10.1016/j.ccm.2018.07.007

Vaccines to Prevent Pneumococcal Community-Acquired Pneumonia

Cornelis H. van Werkhoven^*
, Susanne M. Huijts

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Abstract

Streptococcus pneumoniae is the most frequent pathogen in community-acquired pneumonia and also causes invasive diseases like bacteremia and meningitis. Young children and elderly are especially at risk for pneumococcal diseases and are, therefore, eligible for pneumococcal vaccination in most countries. This reviews provides an overview of the current epidemiology of pneumococcal infections, history and evidence of available pneumococcal polysaccharide and conjugate vaccines, and current recommendations.

Original language	English
Pages (from-to)	733-752
Number of pages	20
Journal	Clinics in chest medicine
Volume	39
Issue number	4
DOIs	https://doi.org/10.1016/j.ccm.2018.07.007
Publication status	Published - 1 Dec 2018

Keywords

Community-acquired pneumonia
Invasive pneumococcal disease
Pneumococcal conjugate vaccine
Pneumococcal polysaccharide vaccine
Pneumococcal vaccines
Streptococcus pneumoniae

Access to Document

10.1016/j.ccm.2018.07.007

van werkhovenFinal published version, 605 KBLicence: Taverne

Cite this

@article{0b180c8fe0974e309599ce536f5c85cb,

title = "Vaccines to Prevent Pneumococcal Community-Acquired Pneumonia",

abstract = "Streptococcus pneumoniae is the most frequent pathogen in community-acquired pneumonia and also causes invasive diseases like bacteremia and meningitis. Young children and elderly are especially at risk for pneumococcal diseases and are, therefore, eligible for pneumococcal vaccination in most countries. This reviews provides an overview of the current epidemiology of pneumococcal infections, history and evidence of available pneumococcal polysaccharide and conjugate vaccines, and current recommendations.",

keywords = "Community-acquired pneumonia, Invasive pneumococcal disease, Pneumococcal conjugate vaccine, Pneumococcal polysaccharide vaccine, Pneumococcal vaccines, Streptococcus pneumoniae",

author = "\{van Werkhoven\}, \{Cornelis H.\} and Huijts, \{Susanne M.\}",

note = "Funding Information: Disclosure Statement: C.H. van Werkhoven reports speaker fees and financial support for thesis printing from Pfizer, and speaker fees from Merck/MSD. S.M. Huijts reports financial support from Pfizer for thesis printing. Both authors were involved in research funded by Pfizer through their institution. Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",

year = "2018",

month = dec,

day = "1",

doi = "10.1016/j.ccm.2018.07.007",

language = "English",

volume = "39",

pages = "733--752",

journal = "Clinics in chest medicine",

issn = "0272-5231",

publisher = "W.B. Saunders",

number = "4",

}

TY - JOUR

T1 - Vaccines to Prevent Pneumococcal Community-Acquired Pneumonia

AU - van Werkhoven, Cornelis H.

AU - Huijts, Susanne M.

N1 - Funding Information: Disclosure Statement: C.H. van Werkhoven reports speaker fees and financial support for thesis printing from Pfizer, and speaker fees from Merck/MSD. S.M. Huijts reports financial support from Pfizer for thesis printing. Both authors were involved in research funded by Pfizer through their institution. Publisher Copyright: © 2018 Elsevier Inc.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Streptococcus pneumoniae is the most frequent pathogen in community-acquired pneumonia and also causes invasive diseases like bacteremia and meningitis. Young children and elderly are especially at risk for pneumococcal diseases and are, therefore, eligible for pneumococcal vaccination in most countries. This reviews provides an overview of the current epidemiology of pneumococcal infections, history and evidence of available pneumococcal polysaccharide and conjugate vaccines, and current recommendations.

AB - Streptococcus pneumoniae is the most frequent pathogen in community-acquired pneumonia and also causes invasive diseases like bacteremia and meningitis. Young children and elderly are especially at risk for pneumococcal diseases and are, therefore, eligible for pneumococcal vaccination in most countries. This reviews provides an overview of the current epidemiology of pneumococcal infections, history and evidence of available pneumococcal polysaccharide and conjugate vaccines, and current recommendations.

KW - Community-acquired pneumonia

KW - Invasive pneumococcal disease

KW - Pneumococcal conjugate vaccine

KW - Pneumococcal polysaccharide vaccine

KW - Pneumococcal vaccines

KW - Streptococcus pneumoniae

UR - https://www.scopus.com/pages/publications/85055750821

U2 - 10.1016/j.ccm.2018.07.007

DO - 10.1016/j.ccm.2018.07.007

M3 - Review article

C2 - 30390745

AN - SCOPUS:85055750821

SN - 0272-5231

VL - 39

SP - 733

EP - 752

JO - Clinics in chest medicine

JF - Clinics in chest medicine

IS - 4

ER -

Vaccines to Prevent Pneumococcal Community-Acquired Pneumonia

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this